Pembrolizumab Dilution: 200 mg in Normal Saline
Pembrolizumab 200 mg should be diluted in 50-250 mL of 0.9% sodium chloride (normal saline) for intravenous infusion 1.
Preparation Details
The most recent oncology guidelines from the Chinese Society of Clinical Oncology (CSCO) 2024 provide specific dilution parameters for pembrolizumab that align with FDA-approved formulations 1:
- Standard dilution volume: 50-250 mL of normal saline
- Final concentration after dilution: Typically 1-10 mg/mL
- Infusion time: Administer over 30 minutes via intravenous infusion
FDA-Approved Formulation
The FDA label confirms pembrolizumab is available as:
- 100 mg/4 mL single-dose vial (25 mg/mL concentration) 2
- Requires dilution prior to administration in either 0.9% sodium chloride or 5% dextrose 2
For a 200 mg dose, you would use two 100 mg/4 mL vials and dilute the total 8 mL in normal saline.
Practical Considerations
Stability data supports extended storage if needed: pembrolizumab diluted to 1 mg/mL in normal saline in polyolefin bags remains stable for at least 1 week at 5°C or room temperature (20°C ± 3°C) 3. However, the FDA label recommends:
- 24 hours at 2-8°C (refrigerated)
- 6 hours at room temperature after dilution 2
Common Dilution Practice
While the range is 50-250 mL, most institutions use 100-250 mL for the 200 mg dose to ensure adequate dilution and ease of administration. The specific volume within this range does not significantly impact efficacy, as pembrolizumab pharmacokinetics are dose-proportional and not concentration-dependent 2.
Key safety point: Always use aseptic technique during preparation, and discard any unused portion from the single-dose vial 2.